TV Networks Put Spo...
Health Care: Drugs
iBio Inc. (IBIO: AMEX)
$0.41 0.01 | 2.50%
05/17/13 - 03:59 PM ET
Company Cash Flow
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -5.68M | -12.14M | -6.08M | -1.91M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -7.32K | -344.08K | 162.34K | -104.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 0.00 | 888.19K | 1.89M | -394.00K |
| (Decrease) Increase In Other Current Liabilities | 53.65K | -76.81K | -296.94K | 56.00K |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 27.00K |
| Other Non-Cash Items | -798.30K | 6.96M | 1.68M | 13.00K |
| Net Cash From Continuing Operations | -6.01M | -5.34M | -2.35M | -2.02M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -6.01M | -5.34M | -2.35M | -2.02M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -245.10K | -94.09K | -576.98K | -1.61M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -245.10K | -94.09K | -576.98K | -1.62M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 9.04M | 7.24M | 2.80M | 0.00 |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 130.00K | 0.00 | 4.66M |
| Net Cash From Financing Activities | 9.04M | 7.37M | 2.80M | 4.66M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 2.78M | 1.93M | -129.31K | 1.02M |
Portfolios with IBIO
- Portfolio NameUser Type
- Usercosmo
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserBiotech88
Latest IBIO Headlines from TheStreet
- 4 Biotech Stocks Under $10 Moving Higher 10.05.12 | 08:10 am
- 5 Stocks Under $10 Setting Up to Break Out 09.13.12 | 12:09 pm
- 10 New Stocks Rated by TheStreet 08.03.11 | 02:08 pm
Press Releases for IBIO
- GE Alliance Awarded Contract To Design New Plant-based Manufacturing Facility In Brazil - PR Newswire 04.09.13 | 07:04 am
- IBio Selects Proprietary Recombinant C1 Inhibitor For Clinical Development - PR Newswire 03.26.13 | 07:03 am
- IBio Adds To IBioModulator Portfolio And Product Pipeline - PR Newswire 03.13.13 | 07:03 am
- IBio Adds New Therapeutic Antibody To Its Pipeline - PR Newswire 03.04.13 | 09:03 am
- IBio, Inc. Receives Anticipated Notice From NYSE MKT That Company Is Below Certain Continued Listing Standards - PR Newswire 03.04.13 | 09:03 am
- IBio And Caliber Biotherapeutics Establish License And Collaboration Relationship - PR Newswire 02.19.13 | 07:02 am
- IBio, Inc. Receives Approval From NYSE MKT Of Compliance Plan - PR Newswire 02.13.13 | 07:02 am
- IBio Announces At-the-Market Equity Offering - PR Newswire 02.01.13 | 09:02 am
- IBio Announces New Appointment To Board Of Directors And New Addition To Executive Management Team - PR Newswire 12.21.12 | 07:12 am
- National Institute Of Health Awards Contract To Support Use Of IBio's Proprietary Technology For Improved Anthrax Vaccine - PR Newswire 12.05.12 | 07:12 am
Partner Headlines for IBIO
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- iBio Announces Proposed Public Offering; No Amount Given - Benzinga 01.09.12 | 04:01 pm
- IBIO: Pharma Stock With Much Downside Risk And Low Upside Potential - Seeking Alpha 11.02.11 | 08:11 am
- iBio Still Overvalued; More Dilution Likely - Seeking Alpha 06.29.11 | 09:06 am
- Trading Resumes: iBio, Inc. - Benzinga 03.08.11 | 01:03 pm
- iBio Overvalued - Seeking Alpha 02.09.11 | 08:02 am
- 4 Stocks for the Aggressive Investor - Seeking Alpha 02.02.11 | 08:02 am
- iBio: A True Paradigm Shift - Seeking Alpha 01.24.11 | 09:01 am
